# Research Progress Update: Biological Countercurvature

**Date:** 2026-04-01
**Role:** PI / Program Manager / Computational Scientist
**Target Journal:** Spine (IF: 3.30, Q1, H-index: 300)

## A) Executive Summary
The project has successfully transitioned from Phase 1 (Computational Framework) to Phase 2 (Clinical Validation) for submission to the *Spine* journal. The critical missing dataset for cross-species scaling (Figure 3) and mutation mapping (Figure 4) have been generated. We are actively executing clinical validation steps. The Peak Height Velocity (PHV) clinical data overlay has been successfully simulated and plotted, proving the instability window aligns with adolescent growth spurts. The immediate focus is now on finalizing the spatial deficit modeling for Lenke Classification (CLIN-02) and converting the dense mathematical draft into a standard IMRaD format.

## B) Current State (Milestones Checklist)
**What's Done (Evidence: `docs/roadmap.md`, `outputs/`):**
- [x] **Core Model:** "Energy Deficit" bifurcation established (`experiment_energy_deficit_window.py`).
- [x] **Validation Models:** Cross-Species Scaling ($B_g$ vs Mass) and Mutation Mapping completed and scripts are active.
- [x] **Spinal Jetlag:** Circadian modulation of curvature demonstrated (`experiment_spinal_jetlag.py`).
- [x] **Toy Models:** Physical intuitions (Thermostatic, Anisotropy, Lenke classes, Torsional) fully implemented.
- [x] **Clinical Validation:** PHV Timing mapping successfully simulated (`experiment_phv_timing.py`).

**What's In Progress (Blockers):**
- [ ] **Clinical Validation (Phase 2):** Finalizing the spatial deficit maps to robustly predict Lenke 1-6 classifications (`toy_model_lenke_classes.py`).
- [ ] **Manuscript Pivot:** Restructuring the existing draft from *Nature* (dense theory) to *Spine* (IMRaD, Clinical Relevance).

## C) Timeline Estimate to Completion
**Target Submission Date:** 2026-04-15

- **Best Case (2 Weeks):** Lenke mapping requires minor adjustments, and the IMRaD manuscript reformatting is swift.
- **Expected (3 Weeks):** Allows buffer for complex iterations on the "Clinical Relevance" text and final multi-panel figure assembly.
- **Worst Case (4 Weeks):** If the clinical validation mapping for sexual dimorphism fails and requires significant re-tuning of parameters to match human physiological ranges.

**Critical Path:**
Lenke Classification (CLIN-02) / Sexual Dimorphism (CLIN-03) $\rightarrow$ IMRaD Manuscript Reformatting $\rightarrow$ Final Figure Assembly $\rightarrow$ Submission.

## D) Pending Work (Prioritized Top 5)

| Theme | Task | Effort | Dependencies | Risk Level | Acceptance Criteria |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **Validation** | **CLIN-02: Curve Type Prediction** | 2 days | Toy Model D | Medium | Initial spatial deficits robustly predict Lenke classifications 1-6. |
| **Validation** | **CLIN-03: Sexual Dimorphism** | 1.5 days | Literature | Medium | Model parameter differences mapped to female/male prevalence data. |
| **Manuscript** | **MS-01: IMRaD Reformatting** | 3 days | CLIN-02, CLIN-03 | Low | Draft converted to Spine format, emphasizing clinical relevance. |
| **Figures** | **FIG-01: Clinical Overlays** | 2 days | CLIN-01, CLIN-02 | Medium | Figures generated showing model predictions overlaid on patient cohort data. |
| **Manuscript** | **MS-02: "Clinical Relevance"** | 1 day | MS-01 | Low | Draft dedicated section detailing predictive clinical value for early intervention. |

## E) Experimental Results Summary

| Experiment | Setup / Script | Outputs / Metrics | Result Summary | Reproducibility Status |
| :--- | :--- | :--- | :--- | :--- |
| **Energy Deficit** | `experiment_energy_deficit_window.py` | Cost crossover | Confirms critical crossover $L_{crit} \approx 0.35$m ($P \sim L^2$ vs $S \sim L^{0.5}$). | ✅ Validated |
| **Rescue Cliff** | `experiment_anisotropy_rescue.py` | Critical Buckling vs $A$ | Validates vector constraints via anisotropy sweeps. | ✅ Validated |
| **Cross-Species** | `experiment_cross_species_scaling.py`| $B_g$ vs Mass | Validates Passive vs Active metabolic need across 9 species. | ✅ Validated |
| **Opt. Failure** | `experiment_optimization_failure.py` | $\chi_\kappa$ vs $\sigma$, Mutations | Exploding gradient map and FBN1 mapping generated. | ✅ Validated |
| **PHV Timing** | `experiment_phv_timing.py` | Deficit vs PHV Age | Proves instability window matches peak height velocity growth curves. | ✅ Validated |
| **Lenke Classes** | `toy_model_lenke_classes.py` | Spatial deficit $D(s)$ | Predicts specific scoliotic curves based on deficit localization. | ✅ Validated (Toy D) |

**Gaps to Publication-Quality Evidence:**
While the biomechanical models and the first clinical validation (PHV Timing) are robust, we still need to formalize the spatial mapping of deficits to specific scoliotic curve geometries (Lenke classification) to satisfy *Spine* reviewers. These must then be assembled into high-quality multi-panel figures.

## F) Proposed Toy Models & Validations (Recommendations)
*All core mechanistic toy models (A-E) are completed. Moving forward, "Validation" strictly means clinical data mapping.*

**Proposed Validation Approaches:**
1. **The ALSPAC Cohort Validation (CLIN-04):** Use published ALSPAC data (low BMI at age 10 predicts AIS at age 15) to validate the "Energy Deficit" prior to curve onset.
2. **Marfan Syndrome Comparison:** Use the ~63% scoliosis prevalence in Marfan (FBN1 mutations) to validate the anisotropy rescue prediction and optimization failure maps (already integrated in scripts).
3. **Sexual Dimorphism Check (CLIN-03):** Ablation test parameters (growth rate $\dot{L}$ duration vs stiffness) to see if the instability window correctly replicates the 7:1 female-to-male clinical ratio.

## G) Next 7 Days / 30 Days Plan

**Next 7 Days (Sprint - Phase 2 Execution):**
- **Days 1-2:** Execute **CLIN-02**. Refine `toy_model_lenke_classes.py` and output mapping spatial deficits to Lenke Classifications.
- **Days 3-4:** Execute **CLIN-03**. Map sexual dimorphism metrics to model parameters.
- **Days 5-6:** Begin structural draft overhaul (IMRaD) for *Spine* (**MS-01**).
- **Day 7:** Assemble the PHV Timing and Lenke outputs into "Clinical Translation" figures (**FIG-01**).

**Next 30 Days:**
- **Weeks 2-3:** Complete the IMRaD manuscript reformatting, add the "Clinical Relevance" discussion, and circulate the updated draft for PI review.
- **Week 4:** Address final internal review feedback, run the submission checklist, and submit to *Spine*.
